To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05447663
Title A Study of Siremadlin Alone and in Combination With Donor Lymphocyte Infusion in Acute Myeloid Leukemia Post-allogeneic Stem Cell Transplant
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA | ESP | DEU

Facility Status City State Zip Country Details
Novartis Investigative Site Augsburg 86179 Germany Details
Novartis Investigative Site Freiburg 79106 Germany Details
Novartis Investigative Site Bergamo BG 24127 Italy Details
Novartis Investigative Site Bologna BO 40138 Italy Details
Novartis Investigative Site Sevilla Andalucia 41013 Spain Details
Novartis Investigative Site Valencia 46026 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field